The application of the rapidly evolving field of single-cell technologies like CyTOF and single-cell RNAseq is allowing identification of novel cell communities that are important in CVD. Based on recent and many ongoing studies we will be able to improve patient-at-risk identification and define new therapeutic strategies for treatment of disease.
Join the discussion during the 4th biennial Symposium of the ESC Working Group on Atherosclerosis and Vascular Biology organised just before the Frontiers in CardioVascular Biomedicine (FCVB) Congress.
ESC Working Group on Atherosclerosis & Vascular Biology contact@escardio.org DD/MM/YYYY
CANCELLED
In light of the current context, FCVB 2020 is postponed to 22-25 April 2021 (also in Budapest). You can find the official message of the ESC Council on Basic Cardiovascular Science (CBCS) online here.
As a consequence, the symposium prior FCVB of the ESC Working Group on Atherosclerosis & Vascular Biology is cancelled. Your health and safety are of the greatest priority to us.
We wish you all the best in these difficult times and look forward to seeing you in the future.
European Society of Cardiology
European Heart House
Les Templiers
2035 Route des Colles
CS 80179 Biot
06903, Sophia Antipolis, FR
Tel.
+33.4.92.94.76.00
Basic Medical Science Center Semmelweis University
Tűzoltó str. 37-47, Distr. IX
1094 Budapest , HU
Our mission: To reduce the burden of cardiovascular disease.